Estimating excess mortality due to female genital mutilation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 08 2023
16 08 2023
Historique:
received:
12
02
2023
accepted:
06
07
2023
medline:
18
8
2023
pubmed:
17
8
2023
entrez:
16
8
2023
Statut:
epublish
Résumé
Globally, over 200 million women and girls have been subjected to Female Genital Mutilation (FGM). This practice, illegal in most countries, often happens in unsanitary conditions and without clinical supervision with consequent bleeding and infection. However, little is known about its contribution to the global epidemiology of child mortality. We matched data on the proportion of girls of a given age group subject to FGM to age-gender-year specific mortality rates during 1990-2020 in 15 countries where FGM is practised. We used fixed-effects regressions to separate the effect of FGM on mortality-rates from variation in mortality in that country in that year. Using our estimated effect, we calculated total annual excess mortality due to FGM. Our estimates imply that a 50% increase in the number of girls subject to FGM increases their 5-year mortality rate by 0.075 percentage point (95% CI [Formula: see text]-[Formula: see text]). This increased mortality rate translates into an estimated 44,320 excess deaths per year across countries where FGM is practised. These estimates imply that FGM is a leading cause of the death of girls and young women in those countries where it is practised accounting for more deaths than any cause other than Enteric Infections, Respiratory Infections, or Malaria.
Identifiants
pubmed: 37587182
doi: 10.1038/s41598-023-38276-6
pii: 10.1038/s41598-023-38276-6
pmc: PMC10432559
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13328Informations de copyright
© 2023. Springer Nature Limited.
Références
Spat Spatiotemporal Epidemiol. 2016 Feb;16:59-76
pubmed: 26919756
Nat Hum Behav. 2022 May;6(5):635-645
pubmed: 35361908
Reprod Health Matters. 2010 Nov;18(36):181-90
pubmed: 21111362
BMJ Open. 2014 Nov 21;4(11):e006316
pubmed: 25416059
Nature. 2016 Oct 27;538(7626):506-509
pubmed: 27732586
Obstet Gynecol Int. 2014;2014:542859
pubmed: 25505915
Science. 2012 Sep 21;337(6101):1482-7
pubmed: 22997325
Fertil Steril. 2010 Feb;93(3):722-4
pubmed: 19028385
Bull World Health Organ. 2010 Apr;88(4):281-8
pubmed: 20431792
BMJ Glob Health. 2019 Jul 15;4(4):e001553
pubmed: 31406589
PLoS One. 2020 Oct 6;15(10):e0238782
pubmed: 33021973
Arch Gynecol Obstet. 2013 Jun;287(6):1137-49
pubmed: 23315098
BMC Public Health. 2015 Oct 08;15:1034
pubmed: 26449728
Science. 2015 Sep 25;349(6255):1446-7
pubmed: 26404811
BMC Public Health. 2013 Oct 03;13:921
pubmed: 24090097
Stud Fam Plann. 2012 Jun;43(2):135-46
pubmed: 23175952
J Sex Med. 2007 Nov;4(6):1666-78
pubmed: 17970975
Lancet. 2018 Sep 8;392(10150):857-865
pubmed: 30173907
Lancet Public Health. 2021 Mar;6(3):e136
pubmed: 33640072
Obstet Gynecol Int. 2013;2013:496564
pubmed: 23878544
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33051284
Lancet. 2015 Mar 7;385(9971):843-4
pubmed: 25773078
J Obstet Gynaecol. 2004 Apr;24(3):281-3
pubmed: 15203627
BMJ Glob Health. 2018 Nov 06;3(5):e000549
pubmed: 30483404
Soc Sci Med. 2002 Jan;54(2):205-20
pubmed: 11824926
Afr J Reprod Health. 2015 Sep;19(3):32-40
pubmed: 26897911
BMC Womens Health. 2022 Nov 4;22(1):433
pubmed: 36333698
BMC Int Health Hum Rights. 2020 Jul 23;20(1):19
pubmed: 32703226
Health Care Women Int. 2013 Oct;34(10):837-59
pubmed: 23489149